The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain. 9 May 2017 Tekcapital plc

("Tekcapital", "the Company" or "the Group")

Final results for the year ended 30 November 2016

A year of considerable progress, where Tekcapital now holds exclusive rights to 59 intellectual properties and reports solid progress on its commercialisation programmes

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces its audited results for the year ended 30 November 2016.

Financial highlights

Revenue increased by 87.7% to US$764,777 (2015: US$407,420)

Operating loss of US$2,558,512 (2015: US$1,460,704)

o Reflecting the investment in and operations of Belluscura Ltd ("Belluscura") during the period

Net assets as at 30 November 2016 of US$3,137,074 (2015: US$3,719,217)

Operational highlights
  • Completed the acquisition of certain assets and the business of Vortechs Group Inc. ("Vortechs Group"), a leading technology transfer executive search firm.

  • Significant acquisition and development of Intellectual Property during the period including: o Acquisition of US patent #8,900,650 B1 for low-sodium salt compositions, which has the potential to enable the commercialisation of a 1:1 replacement for regular salt in a variety of applications including table top, dry snacks such as chips and crisps,

    popcorn, cereals, and other dry surface applications that have salt in spice mixes.

    o Issuance and exclusive license of a second patent (US patent #9,516,885) from the University of Arkansas, for the Crackle-baked® process.

  • Signed a strategic alliance agreement with Bajainnova SAPI de CV, the Mexico-based based technology transfer company, to market all of Tekcapital's services in Mexico.

  • Successfully concluded two private placings to raise more than US$2 million for the development of Belluscura during the period.

    Post-period end highlights
  • Successful test-production and independent taste testing of µSalt™, Tekcapital's proprietary, low-sodium salt product

  • Launched a new software App which facilitates the global searching of university IP

  • Out-license negotiations in respect of µSalt™, Crackle-baked® and Tekcapital's portfolio of optics patents remain ongoing

  • Tekcapital raised a total of approximately US$3.0m, before expenses, to further the development of the Company through an oversubscribed placing of 6,968,500 at 35 pence per share

  • Belluscura acquired the entire issued share capital of Nanotether Discovery Science Ltd ("Nanotether") for a total consideration of approximately £265,000 which was satisfied entirely by the issue of new shares in Belluscura

  • Belluscura raised approximately US$1.7m in May 2017 with a post-money valuation of US$7.6m, to further investment in the Company's existing products and products in development and sales and marketing. Tekcapital currently owns approximately 48% of the shares of Belluscura

Commenting on the results, Dr. Clifford Gross, Executive Chairman of Tekcapital plc, said: "Having continued to develop its existing business, the Board is confident that continued investment in growth remains the right policy. This strategy resulted in the acquisition of valuable intellectual property rights and the acquisition of Vortechs Group, and increased revenue in 2016 by approximately 87% as compared with 2015. Further, we believe our strategy will result in the ongoing development of the Company's products and business.

The Directors remain confident that the Company will continue to increase revenues from its service offerings combined with licensing revenues from its IP portfolio. As a result of the quickening pace of innovation, an increasing number of companies are making use of innovative ideas sourced exogenously, and with patented university and corporate technologies an increasingly valued currency, the market opportunity for the Group is both large and should continue to grow apace."

The Company's annual report and accounts for the year ended 30 November 2016 will be posted to shareholders today and will be available on the Company's website shortly.

Contacts Tekcapital Plc

Clifford M. Gross, Ph.D. info@tekcapital.com

Allenby Capital Limited (Nominated Adviser & Joint Broker) +44 (0) 20 3328 5656

Jeremy Porter / Alex Brearley

Dowgate Capital Stockbrokers (Joint Broker) +44 (0) 1293 517744

David Poutney / James Serjeant

Walbrook PR Ltd +44 (0) 20 7933 8780

Paul Cornelius / Helen Cresswell / Sam Allen tekcapital@walbrookpr.com

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital creates value from new, university-developed intellectual properties. With its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85 Chairman's statement Review of the Business

Tekcapital is passionate about creating value from university intellectual property ("IP"). In the past year we have made considerable progress.

We continue to provide technology sourcing services for our corporate clients but also provide important additional technology transfer services:

  • In 2014, we announced the acquisition of Invention Evaluator, the turn-key service that assesses the commercial potential of new technologies. We continue to expand the client base for the service and have added a direct sales team in our US office. Additionally, we have recently up-graded the format of the reports to enhance both their information content and marketability as well as refreshed the website. Invention Evaluator continues to perform well and demand for the Group's Invention Evaluator service remains strong with customers consisting of universities, research centres and corporations world-wide. The service has been successfully integrated with our existing offering and has attracted significant client interest.

  • In 2016, we announced the acquisition of the business and certain assets of the Vortechs Group, a leading technology transfer personnel placement firm in North America. This expands our technology transfer offerings and enables us to provide technology transfer professionals as well as new technologies to both our clients and university suppliers. The Vortechs Group has been completely integrated into the Tekcapital offerings and the Board is of the view that it has performed well post-acquisition and has been a contributor to Group revenue growth in 2016.

  • Our investment in Belluscura, continues to develop, and is an indication of how we are able to leverage patent acquisition. They have recently launched a number of products in both the US and UK and have acquired the rights to a portfolio of oxygen concentrator patents and know-how which Belluscura is seeking to develop into a commercial product in 2017.

The Group's technology out-licensing service leverages its competencies to identify and acquire particularly promising new IP which management believes can be readily out-licensed to corporations. This service extends the Group's impact by directly commercialising innovative university and corporate developed technologies and also has the potential to capture for the Group's own benefit more of the value realised when innovative ideas are successfully commercialised. Since inception two years ago, this new effort has grown rapidly. As of the date of this report we have secured exclusive licenses to 59 patents, applications and industrial designs.

We believe that there is a significant value to be realised from the patent rights that we have acquired to-date, and we are strategically moving forward with our commercialisation efforts, including seeking to out-license our patents and IP. Negotiations are on-going with uSalttm, Crackle-bakedtm and our head-mounted display/optics patents portfolio and we will update the market in due course as specific properties are out licensed. We are also continuing with our prototype development of the in-shoe energy harvester to generate power from human motion for recharging mobile devices. In December 2016, we announced an out-licensing of Tekcapital's intellectual property for the improvement of air conditioning efficiency and a strategic alliance with Wecast Technology Group.

As announced on 17 June 2016, as part of the establishment of Belluscura, Tekcapital novated to Belluscura its worldwide exclusive licenses to a patent and related patent application for Saliva Glucose Measurement Technology for companion animals (and humans), to provide Belluscura the opportunity to commercialise a patented technology relating to the non-invasive measurement of

glucose in saliva for the treatment of diabetes. This technology is licensed from and was developed by Arizona State University and further details on these licences were announced by Tekcapital on 2 April 2015 and 14 March 2016.

Post end of period, in January 2017, Tekcapital completed a placing of 6,968,500 new ordinary shares at a price of 35 pence per share to raise a total of approximately US$3.0 million before expenses.

Additionally, post end of period, on 3 May 2017, we were pleased to have also announced a private placement into Belluscura, of approximately US$1.7 million. This brings Tekcapital's ownership interest in Belluscura to 48%. Based on the post money valuation of Belluscura at the close of the recent financing, Tekcapital's ownership stake is valued at approximately US$3.6m. Further, Belluscura is exploring an IPO in 2017.

Financial review

The Group is still in its early stages of development. Funds raised from investors are being applied, along with revenues generated, pursuing our strategic objectives. These are principally to grow the customer base for our technology transfer services and to acquire, refine and sell-on licences for certain university and corporate intellectual properties.

Our technology transfer services have generated Group sales for the period to 30 November 2016 of US$764,777 (as compared with sales of US$407,420 in 2015) with losses of US$2,719,415 as compared with losses of US$1,412,964 in 2015. The Vortechs Group was a contributor to Group revenue growth in 2016. The increase in expenditures during 2016 reflects the investment in and operations of Belluscura during the period.

The Group's net assets stood at US$3,137,074 as at the end of the period, due mainly to shareholder investment, augmented by technology acquisitions. The Group's liabilities of US$484,825 as at the end of the period are very low as its costs have been settled without delay using available funds.

Current Trading and Outlook

Having continued to develop its existing business, the Board is confident that continued investment in growth remains the right policy. This strategy led to the acquisition of valuable intellectual property rights and the acquisition of Vortechs Group, which contributed to increased revenue in 2016 compared with 2015. Further, we believe our strategy will result in further increases in revenue and the continued growth of the Group in the future.

Post end of period, the Group also launched a new mobile device application ('App'), available on iPhone, which facilitates the searching of intellectual properties from universities worldwide. The app's objective is to allow the user to locate, review and license university technologies with ease and is a very complimentary product to the Group's other services which services to make it a gateway for organic discovery of the rest of the Company's offerings.

The Directors remain confident that increased revenues will arise from our service offerings combined with the near-term sub-licensing of its IP portfolio. With an increasing number of companies making ever faster and more disruptive use of innovative ideas sourced exogenously, and with patented university and corporate technologies an increasingly valued currency, the market opportunity for the Group is both large and should continue to grow apace.

Dr Clifford M Gross Executive Chairman 9 May 2017

Tekcapital plc published this content on 09 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 May 2017 08:40:19 UTC.

Original documenthttp://tekcapital.com/wp-content/uploads/2014/01/Tekcapital-plc-Final-Results-1.pdf

Public permalinkhttp://www.publicnow.com/view/6D8DC49A41A8F01895F32F86C93C3C756E6D7855